Vestal Point Capital, LP

Position in RGEN — Repligen Corp

CIK 1974915 NEW YORK, NY

Position in RGEN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$108,983,500

+$95,383,120 QoQ

Shares Held

925,000

+1014.5% QoQ

Ownership

1.64%

of shares outstanding

% of Portfolio

3.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Vestal Point Capital, LP holds $196,951,519 across 5 Medical Instruments & Supplies names. RGEN ranks #1 (55.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RGEN	Repligen Corp This page	925,000	$108,983,500
2	ALC	Alcon Inc	800,000	$60,280,000
3	WST	West Pharmaceutical Services Inc	75,000	$18,798,000
4	AVR	Anteris Technologies Global Corp.	1,144,780	$6,353,529
5	NYXH	Nyxoah SA	868,661	$2,536,490

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$108,983,500	925,000	+1014.5%	Shares	Sole	2026-05-15
2025-12-31	$13,600,380	83,000	-79.2%	Shares	Sole	2026-02-17
2025-09-30	$53,468,000	400,000	—	Shares	Sole	2025-11-14
No filing history on record for this holder in this stock.